EziSurg Medical

EziSurg Medical was founded in 2011 and is headquartered in Shanghai. It is a high-tech company specializing in the R&D and industrialization of advanced minimally invasive surgical medical devices. With the mission of “to advance MIS technologies, alleviate the suffering of patients, and improve the quality of life,” the company is committed to building a preferred global provider of reliable, accessible and affordable comprehensive MIS solutions.

At present, EziSurg Medical has established four major product lines — surgical stapling series, surgical energy platform surgical endoscopy platform, and surgical support. The products are mainly applied in minimally invasive surgical procedures of thegeneral, bariatric, thoracic, colorectal and gynecological, contributing to precise, efficient, and stable clinical operations.

Adhering to the philosophy of craftsmanship and social responsibility, EziSurg Medical has achieved solid innovation results worldwide, owning over 350 global patents and 220 global certifications. Multiple products have obtained U.S. FDA registration and CE MDR certification. To date, the company’s products have been adopted by more than 1,400 medical institutions in China (with over 40% being tertiary grade-A hospitals) and exported to nearly 90 countries and regions around the world.

After more than a decade of innovation and development, EziSurg Medical has become a leading enterprise in the field of minimally invasive oncology surgery in China. In the future, as the global medical device industry continues to grow rapidly, EziSurg Medical will continue to rely on innovative technologies and high-quality products with significant clinical value to accelerate its expansion into the global high-end medical device market, contributing to the advancement of minimally invasive surgery worldwide.